~~<i id='F538402ABF'><strike id='F538402ABF'><tt id='F538402ABF'><pre id='F538402ABF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

focus

author：fashion 2025-10-02 14:51:36 - browse：62

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： AstraZeneca to buy developer of next

knowledge

explore

Wikipedia

hotspot

knowledge

hotspot

MikeReddyforSTATIwasrecentlyworkingwithayoungmotherwhostruggledwithdepressionandanxietyinthedifficul

WSS

Florida Supreme Court upholds state's abortion ban

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Stop the failed accountable care organization experiment

SCOTUS questions limit to govt efforts to fight misinformation

Four alarming medical procedures we’re glad history forgot

Virtual Event: March of the Biosimilars

knowledge

focus

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

Hundreds died while taking an arthritis drug, but nobody alerted patients

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Positive childhood experiences can help future health

Hepatitis C has a cure — but many Americans still lack access to it

Bird flu in dairy cattle: New measures to control spread to humans

How to save PrEP access — and even expand it

Future doctors should be trained to promote social change

Activists slam private health insurers over coverage restrictions

People with mental disorders often marry others with same

explore

Gene editing the human germline: What are the risks?

Trial using CRISPR to edit HIV out of cells disappoints

Methadone treatment changes are coming. Do they go far enough?

Health AI adoption puts security, privacy startups on investors' radar

People with mental disorders often marry others with same

First Opinion on colorectal cancer screening: letter and response

Wikipedia

hotspot

knowledge

hotspot